Clinical Trial Update: To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of GT20029 Gel and GT20029 Solution in healthy subjects; the trial has completed. Conditions …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne
• Alopecia

Drugs mentioned

• GT20029 Gel (GT20029)
• GT20029 Solution (GT20029)

Snippet

Sponsor: Suzhou Kintor Pharmaceutical Inc, | Conditions: Acne, Alopecia | Phase 1 | Status: COMPLETED